1. Home
  2. CBLL vs VOR Comparison

CBLL vs VOR Comparison

Compare CBLL & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CeriBell Inc.

CBLL

CeriBell Inc.

N/A

Current Price

$27.56

Market Cap

935.3M

Sector

N/A

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$20.08

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBLL
VOR
Founded
2014
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
935.3M
1.1B
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
CBLL
VOR
Price
$27.56
$20.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
10
Target Price
$31.57
★ $39.00
AVG Volume (30 Days)
647.2K
★ 715.9K
Earning Date
11-03-2026
10-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 56.93
N/A
EPS
★ N/A
N/A
Revenue
★ $89,063,000.00
N/A
Revenue This Year
$29.72
N/A
Revenue Next Year
$27.43
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 36.09
N/A
52 Week Low
$11.75
$6.50
52 Week High
$28.89
$26.00

Technical Indicators

Market Signals
Indicator
CBLL
VOR
Relative Strength Index (RSI) 56.29 52.13
Support Level $22.96 $17.44
Resistance Level $28.11 $20.11
Average True Range (ATR) 1.67 1.20
MACD -0.11 0.13
Stochastic Oscillator 81.38 55.69

Price Performance

Historical Comparison
CBLL
VOR

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: